Marina Biotech, Inc. (Formerly Known as MDRNA, Inc.) Acquires RNA Delivery Assets of Novosom
7/28/2010 6:21:14 AM
More...
|
Novosom Acquires Exclusive License from Isis Pharmaceuticals, Inc. (ISIS) for CD40-Targeted Antisense Inhibitors
8/26/2008 6:17:34 AM
More...
|
Novosom Granted US and European Patents for RNAi-Delivering Smarticles(R)
5/14/2008 9:06:17 AM
More...
|
Novosom Acquires Exclusive Option for CD40-Targeted Antisense Inhibitors From Isis Pharmaceuticals, Inc. (ISIS)
4/11/2007 11:15:44 AM
More...
|
ProNAi Therapeutics, Inc. and Novosom Announce Collaboration to Enable Delivery of DNAi(R)-Based Cancer Therapeutics
3/6/2007 1:12:57 PM
More...
|
Nucleonics Inc. And Novosom Collaborate To Apply Novosom's SMARTICLES Delivery Technology To Nucleonics' eiRNA Approach To Hepatitis B And C Therapeutics
10/19/2005 5:08:46 PM
More...
|